======= RWDD3 ======= == Gene Information == * **Official Symbol**: RWDD3 * **Official Name**: RWD domain containing 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25950|25950]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3V2|Q9Y3V2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RWDD3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RWDD3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615875|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Enhancer of SUMO conjugation. Via its interaction with UBE2I/UBC9, increases SUMO conjugation to proteins by promoting the binding of E1 and E2 enzymes, thioester linkage between SUMO and UBE2I/UBC9 and transfer of SUMO to specific target proteins which include HIF1A, PIAS, NFKBIA, NR3C1 and TOP1. Isoform 1 and isoform 2 positively regulate the NF-kappa-B signaling pathway by enhancing the sumoylation of NF-kappa-B inhibitor alpha (NFKBIA), promoting its stabilization which consequently leads to an increased inhibition of NF-kappa-B transcriptional activity. Isoform 1 and isoform 2 negatively regulate the hypoxia-inducible factor-1 alpha (HIF1A) signaling pathway by increasing the sumoylation of HIF1A, promoting its stabilization, transcriptional activity and the expression of its target gene VEGFA during hypoxia. Isoform 2 promotes the sumoylation and transcriptional activity of the glucocorticoid receptor NR3C1 and enhances the interaction of SUMO1 and NR3C1 with UBE2I/UBC9. Has no effect on ubiquitination. {ECO:0000269|PubMed:17956732, ECO:0000269|PubMed:22009797, ECO:0000269|PubMed:23469069, ECO:0000269|PubMed:23508108}. |RWD| |DUF1115| |regulation of hypoxia-inducible factor-1alpha signaling pathway| |positive regulation of hypoxia-inducible factor-1alpha signaling pathway| |positive regulation of cellular response to hypoxia| |positive regulation of protein sumoylation| |regulation of cellular response to hypoxia| |regulation of protein sumoylation| |negative regulation of NF-kappaB transcription factor activity| |positive regulation of protein modification by small protein conjugation or removal| |negative regulation of DNA-binding transcription factor activity| |regulation of protein modification by small protein conjugation or removal| |regulation of DNA-binding transcription factor activity| |regulation of cellular response to stress| |negative regulation of molecular function| |positive regulation of protein modification process| |regulation of response to stress| |positive regulation of cellular protein metabolic process| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of protein modification process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16130 * **Expression level (log2 read counts)**: 4.02 {{:chemogenomics:nalm6 dist.png?nolink |}}